NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its robotic magnetic navigation (RMN) systems include Genesis RMN and Niobe systems. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $26.6M | $35.0M | $28.1M | $26.8M | $26.9M | $32.4M |
| Gross profit | $19.0M | $23.2M | $18.5M | $14.9M | $14.6M | $17.1M |
| Operating income | -$6.7M | -$12.9M | -$18.8M | -$21.8M | -$24.7M | -$22.1M |
| Net income | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| Diluted EPS | -$0.11 | -$0.16 | -$0.26 | -$0.27 | -$0.30 | -$0.25 |
| Operating cash flow | -$3.5M | -$2.9M | -$8.4M | -$9.1M | -$8.5M | -$13.7M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 71.2% | 66.3% | 65.6% | 55.5% | 54.2% | 52.7% |
| Operating margin | -25.2% | -36.8% | -66.7% | -81.6% | -91.9% | -68.3% |
| Net margin | -25.0% | -30.6% | -65.0% | -77.4% | -89.3% | -66.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.5M | $9.2M | $6.3M | $7.5M | $8.8M | $7.5M | $8.6M | $6.3M |
| Gross profit | $3.3M | $4.1M | $3.2M | $4.1M | $4.6M | $4.1M | $4.3M | $3.8M |
| Operating income | -$6.0M | -$6.3M | -$7.6M | -$5.9M | -$4.0M | -$6.6M | -$5.6M | -$6.0M |
| Net income | -$5.8M | -$6.2M | -$7.5M | -$5.8M | -$3.8M | -$6.5M | -$5.5M | -$5.9M |
| Diluted EPS | -$0.07 | -$0.08 | -$0.09 | -$0.07 | -$0.05 | -$0.07 | -$0.06 | -$0.06 |
| Operating cash flow | -$3.1M | -$4.3M | $1.3M | -$1.8M | -$3.7M | -$4.2M | -$4.0M | -$3.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 73.6% | 44.6% | 50.7% | 54.4% | 52.0% | 54.9% | 50.1% | 60.3% |
| Operating margin | -133.7% | -69.0% | -120.3% | -79.3% | -45.2% | -87.8% | -65.4% | -95.1% |
| Net margin | -129.6% | -67.3% | -118.5% | -77.9% | -43.5% | -86.6% | -64.0% | -93.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | SHAMIR NACHUM | Award | 43,103 | $0.00 | $0.00 | filing |
| 2026-07-01 | Benfer David | Award | 43,103 | $0.00 | $0.00 | filing |
| 2026-07-01 | Levin Ross B | Award | 43,103 | $0.00 | $0.00 | filing |
| 2026-07-01 | Myriam Curet | Award | 43,103 | $0.00 | $0.00 | filing |
| 2026-07-01 | Fischel Nathan | Award | 43,103 | $0.00 | $0.00 | filing |
| 2026-07-01 | Menawat Arun Swarup | Award | 43,103 | $0.00 | $0.00 | filing |
| 2026-01-02 | Menawat Arun Swarup | Award | 46,948 | $0.00 | $0.00 | filing |
| 2026-01-02 | Benfer David | Award | 46,948 | $0.00 | $0.00 | filing |
| 2026-01-02 | Myriam Curet | Award | 46,948 | $0.00 | $0.00 | filing |
| 2026-01-02 | Fischel Nathan | Award | 46,948 | $0.00 | $0.00 | filing |
| 2026-01-02 | Levin Ross B | Award | 46,948 | $0.00 | $0.00 | filing |
| 2026-01-02 | SHAMIR NACHUM | Award | 46,948 | $0.00 | $0.00 | filing |
| 2025-11-17 | Isaac Paul J | Buy | 10,000 | $2.18 | $21,800.00 | filing |
| 2025-11-14 | Isaac Paul J | Buy | 20,000 | $2.24 | $44,800.00 | filing |
| 2025-07-01 | Fischel Nathan | Award | 43,668 | $0.00 | $0.00 | filing |
| 2025-07-01 | Levin Ross B | Award | 43,668 | $0.00 | $0.00 | filing |
| 2025-07-01 | Benfer David | Award | 43,668 | $0.00 | $0.00 | filing |
| 2025-07-01 | Myriam Curet | Award | 43,668 | $0.00 | $0.00 | filing |
| 2025-07-01 | SHAMIR NACHUM | Award | 43,668 | $0.00 | $0.00 | filing |
| 2025-07-01 | Menawat Arun Swarup | Award | 43,668 | $0.00 | $0.00 | filing |
Latest 20 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.